Clinical Trials Browser

Phase 2 × INDUSTRY × infigratinib × Clear all

NCT06206278 2024-08-14

Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT02159066 2024-03-05

LOGIC-2

Phase 2 Completed

158 enrolled 40 charts

Melanoma

NCT05019794 2022-06-27

FGFR

Phase 2 Unknown

Gastrointestinal

Acrocephalosyndactylia, Stomach Neoplasms

NCT01975701 2019-12-04

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Phase 2 Completed

26 enrolled 10 charts

Glioblastoma

NCT02160041 2019-06-18

CBGJ398XUS04

Phase 2 Terminated

84 enrolled 15 charts

Other hematologic neoplasm

Hematologic Neoplasms